Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Jul 8:(3):CD006324.
doi: 10.1002/14651858.CD006324.pub2.

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia

Andrea Cipriani  1 , Marianna Boso, Corrado Barbui
Affiliations
Meta-Analysis

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia

Andrea Cipriani et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and duration. The need to provide effective therapeutic interventions to patients who do not have an optimal response to clozapine is the most common reason for simultaneously prescribing a second antipsychotic drug in combination with clozapine.

Objectives: To determine the efficacy and tolerability of various clozapine combination strategies with antipsychotics in people with treatment resistant schizophrenia.

Search strategy: We searched the Cochrane Schizophrenia Group Trials Register (March 2008) and MEDLINE (up to November 2008). We checked reference lists of all identified randomised controlled trials and requested pharmaceutical companies marketing investigational products to provide relevant published and unpublished data.

Selection criteria: We included only randomised controlled trials recruiting people of both sexes, aged 18 years or more, with a diagnosis of treatment-resistant schizophrenia (or related disorders) and comparing clozapine plus another antipsychotic drug with clozapine plus a different antipsychotic drug.

Data collection and analysis: Two review authors independently extracted data and resolved disagreement by discussion with third member of the team. When insufficient data were provided, we contacted the study authors.

Main results: Three small (range of number of participants 28 to 60) randomised controlled trials were included in the review. Even though results from individual studies did not find that one combination strategy is better than the others, the methodological quality of included studies was too low to allow authors to use the collected data to answer the research question correctly.

Authors' conclusions: In this review we considered the risk of bias too high because of the poor quality of the retrieved information (small sample size, heterogeneity of comparisons, flaws in the design, conduct and analysis). Although clinical guidelines recommend a second antipsychotic in addition to clozapine in partially responsive patients with schizophrenia, the present systematic review was not able to show if any particular combination strategy was superior to the others. New, properly conducted, randomised controlled trials independent from the pharmaceutical industry need to recruit many more patients to give a reliable estimate of effect or of no effect of antipsychotics as combination treatment with clozapine in patients who do not have an optimal response to clozapine monotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality item presented as percentages across all included studies
Figure 2
Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality item for each included study
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

    1. Genç Y, Taner E, Candansayar S. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. Advances in Therapy. 2007;24(1):1–13. - PubMed
    1. Kong QR. Sulpiride clozapine combined high and low doses observed in the treatment of schizophrenia. Shandong Archives of Psychiatry. 2001;14:138–9.
    1. Zink M, Kuwilsky A, Krumm B, Dressing H. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Journal of Psychopharmacology. 2009;23:305–14. - PubMed

References to studies excluded from this review

    1. Bao XQ. A double-blind study on the effect of clozapine penfluridol and chlorpromazine in the treatment of schizophrenia. Chung Hua Shen Ching Ching Shen Ko Tsa Chih [Chinese Journal of Neurology and Psychiatry] 1988;21(5):274–6. - PubMed
    1. Cao HJ, You HF, Fan FL, Zhang J. The control study of risperidone and clozapine for the treatment-resistant schizophrenia. Chinese Journal of Medicine Research. 2003;3(4):316–9.
    1. Cooper D, Moisan J, Gaudet M, Abdous B, Gregoire JP. Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia. Canadian Journal of Psychiatry. 2005;50(14):901–8. - PubMed
    1. Gerlach J, Simmelsgaard H. Tardive dyskinesia during and following treatment with haloperidol, haloperidol+ biperiden, thioridazine, and clozapine. Psychopharmacology. 1978;59(2):105–12. - PubMed
    1. Glick ID, Zaninelli R, Hsu C, Young FK, Weiss L, Gunay I, Kumar V. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. Journal of Clinical Psychiatry. 2004;65(5):679–85. - PubMed

References to ongoing studies

    1. Randomised Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. Ongoing study. 2006 Sep;

Additional references

    1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ. 1996;313:1200. - PMC - PubMed
    1. American Psychiatric Association . Practice guidelines for the treatment of patients with schizophrenia. 2nd Edition American Journal of Psychiatry; 2004. pp. 1–114.
    1. Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 1998;18:63–101. - PubMed
    1. Barbui C, Signoretti A, Mule S, Boso M, Cipriani A. Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophrenia Bulletin. 2009;35(2):458–68. DOI: 10.1093/schbul/sbn030. - PMC - PubMed
    1. Barnes TR. A rating scale for drug-induced akathisia. British Journal of Psychiatry. 1989;154:672–6. - PubMed

MeSH terms